Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
Macdonell R, Nagels G, Laplaud DA, Pozzilli C, de Jong B, Martins da Silva A, Nicholas R, Lechner-Scott J, Gaebler JA, Agarwal S, Wang P, Yeh M, Hovenden M, Soelberg Sørensen P.
Macdonell R, et al. Among authors: nagels g.
Mult Scler. 2016 Jun;22(7):944-54. doi: 10.1177/1352458515606809. Epub 2015 Oct 7.
Mult Scler. 2016.
PMID: 26447066
Clinical Trial.